With over 13 years of experience, we have supported pharmaceutical and therapeutic companies in ensuring the genomic integrity of their therapies. Our expert scientific team offers consultative services to facilitate your IND filing. Our suite of services is designed to monitor and characterize genome editing outcomes. By crafting a customized study plan with you, we help enable even the most unique therapeutic pipelines.

We work with you every step of the way to ensure the safety and genomic integrity of your drug product, from the bench to the bedside. From pivotal batch analysis of your cells to on- and off-target editing effects, we provide you with a comprehensive data set for your regulatory filing.